Washington Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $834K | Sell |
6,933
-100
| -1% | -$11.5K | 0.7% | 32 |
|
|
2025
Q4 | $740K | Sell |
7,033
-2,000
| -22% | -$188K | 0.6% | 41 |
|
|
2025
Q3 | $758K | Sell |
9,033
-345
| -4% | -$28.4K | 0.54% | 41 |
|
|
2025
Q2 | $742K | Hold |
9,378
| – | – | 0.55% | 41 |
|
|
2025
Q1 | $842K | Sell |
9,378
-2,265
| -19% | -$211K | 0.68% | 34 |
|
|
2024
Q4 | $1.16M | Sell |
11,643
-300
| -3% | -$30.9K | 0.91% | 18 |
|
|
2024
Q3 | $1.36M | Sell |
11,943
-75
| -0.6% | -$8.91K | 1.05% | 17 |
|
|
2024
Q2 | $1.49M | Sell |
12,018
-1,700
| -12% | -$219K | 1.26% | 11 |
|
|
2024
Q1 | $1.81M | Sell |
13,718
-795
| -5% | -$98K | 1.47% | 9 |
|
|
2023
Q4 | $1.58M | Sell |
14,513
-995
| -6% | -$103K | 1.35% | 10 |
|
|
2023
Q3 | $1.6M | Sell |
15,508
-50
| -0.3% | -$5.39K | 1.47% | 9 |
|
|
2023
Q2 | $1.8M | Hold |
15,558
| – | – | 1.53% | 8 |
|
|
2023
Q1 | $1.66M | Sell |
15,558
-5,450
| -26% | -$588K | 1.47% | 9 |
|
|
2022
Q4 | $2.33M | Sell |
21,008
-700
| -3% | -$71.6K | 2.15% | 6 |
|
|
2022
Q3 | $1.87M | Sell |
21,708
-250
| -1% | -$22.3K | 1.88% | 6 |
|
|
2022
Q2 | $2M | Sell |
21,958
-315
| -1% | -$27.9K | 1.92% | 6 |
|
|
2022
Q1 | $1.83M | Sell |
22,273
-245
| -1% | -$19.3K | 1.51% | 10 |
|
|
2021
Q4 | $1.73M | Sell |
22,518
-470
| -2% | -$37.4K | 1.4% | 13 |
|
|
2021
Q3 | $1.73M | Buy |
22,988
+3,935
| +21% | +$299K | 1.53% | 8 |
|
|
2021
Q2 | $1.48M | Sell |
19,053
-1,271
| -6% | -$94.5K | 1.79% | 13 |
|
|
2021
Q1 | $1.5M | Buy |
20,324
+2,007
| +11% | +$148K | 1.39% | 12 |
|
|
2020
Q4 | $1.43M | Buy |
18,317
+618
| +3% | +$47.3K | 1.36% | 13 |
|
|
2020
Q3 | $1.4M | Hold |
17,699
| – | – | 1.44% | 17 |
|
|
2020
Q2 | $1.31M | Sell |
17,699
-3,406
| -16% | -$256K | 1.45% | 16 |
|
|
2020
Q1 | $1.55M | Sell |
21,105
-8,069
| -28% | -$634K | 1.95% | 10 |
|
|
2019
Q4 | $2.53M | Sell |
29,174
-105
| -0.4% | -$8.62K | 2.18% | 9 |
|
|
2019
Q3 | $2.35M | Hold |
29,279
| – | – | 2.3% | 7 |
|
|
2019
Q2 | $2.34M | Buy |
29,279
+151
| +0.5% | +$11.6K | 2.66% | 3 |
|
|
2019
Q1 | $2.31M | Sell |
29,128
-5,450
| -16% | -$408K | 2.62% | 4 |
|
|
2018
Q4 | $2.52M | Sell |
34,578
-262
| -0.8% | -$18.5K | 2.92% | 4 |
|
|
2018
Q3 | $2.36M | Sell |
34,840
-891
| -2% | -$56.8K | 2.26% | 13 |
|
|
2018
Q2 | $2.07M | Hold |
35,731
| – | – | 2.13% | 16 |
|
|
2018
Q1 | $1.86M | Hold |
35,731
| – | – | 1.86% | 18 |
|
|
2017
Q4 | $1.92M | Buy |
35,731
+813
| +2% | +$45.1K | 1.92% | 18 |
|
|
2017
Q3 | $2.13M | Hold |
34,918
| – | – | 2.27% | 14 |
|
|
2017
Q2 | $2.13M | Hold |
34,918
| – | – | 2.4% | 17 |
|
|
2017
Q1 | $2.12M | Hold |
34,918
| – | – | 2.46% | 14 |
|
|
2016
Q4 | $1.96M | Buy |
34,918
+151
| +0.4% | +$8.84K | 2.42% | 18 |
|
|
2016
Q3 | $2.07M | Hold |
34,767
| – | – | 2.85% | 10 |
|
|
2016
Q2 | $1.91M | Sell |
34,767
-4,926
| -12% | -$262K | 2.72% | 13 |
|
|
2016
Q1 | $2M | Buy |
+39,693
| New | +$1.94M | 1.47% | 17 |
|
|
2013
Q3 | – | Sell |
-50,618
| Closed | -$2.24M | – | 190 |
|
|
2013
Q2 | $2.24M | Buy |
+50,618
| New | +$2.26M | 0.58% | 76 |
|
Other funds holding MRK
VCM
VPM
Washington Capital Management's MRK Position: Q1 2026 in Review
Washington Capital Management reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $11.5K and leaving 6,933 shares worth $834K. The position accounts for 0.7% of the portfolio, ranked #32.
Washington Capital Management first reported a position in MRK in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.53M in Q4 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Washington Capital Management held 6,933 shares of Merck worth $834K as of Q1 2026.
- Washington Capital Management sold 100 Merck shares in Q1 2026, an estimated $11.5K.
- Merck made up 0.7% of Washington Capital Management's portfolio in Q1 2026, its #32 holding.
- Washington Capital Management first reported a position in Merck in Q2 2013 and has held it in 42 quarters since.
- Washington Capital Management's Merck position peaked at $2.53M in Q4 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Washington Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.